Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Patents Regarding Cancer and MS Added to Bioniche’s and BioMS’ Portfolio, Respectively

Bioniche received three patents related to its technology for treatment and prediction, and BioMS’ was regarding prediction of MS therapy efficacy.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »